111 related articles for article (PubMed ID: 1389479)
1. Anti-neoplastic action of peritoneal macrophages following oral administration of ether analogues of lysophospholipids.
Ngwenya BZ; Fiavey NP; Mogashoa MM
Eur J Cancer; 1992; 28A(10):1637-42. PubMed ID: 1389479
[TBL] [Abstract][Full Text] [Related]
2. Activation of peritoneal macrophages by orally administered ether analogues of lysophospholipids.
Ngwenya BZ; Fiavey NP; Mogashoa MM
Proc Soc Exp Biol Med; 1991 May; 197(1):91-7. PubMed ID: 1850526
[TBL] [Abstract][Full Text] [Related]
3. Activation of mouse macrophages by alkylglycerols, inflammation products of cancerous tissues.
Yamamoto N; St Claire DA; Homma S; Ngwenya BZ
Cancer Res; 1988 Nov; 48(21):6044-9. PubMed ID: 3167855
[TBL] [Abstract][Full Text] [Related]
4. Activation of macrophages by ether analogues of lysophospholipids.
Yamamoto N; Ngwenya BZ; Sery TW; Pieringer RA
Cancer Immunol Immunother; 1987; 25(3):185-92. PubMed ID: 2824051
[TBL] [Abstract][Full Text] [Related]
5. A serum factor for macrophage activation after in vitro dodecylglycerol treatment of mouse lymphocytes.
Homma S; Millman I; Yamamoto N
Immunol Cell Biol; 1990 Apr; 68 ( Pt 2)():137-42. PubMed ID: 1696561
[TBL] [Abstract][Full Text] [Related]
6. Activation of mouse peritoneal macrophages by lysophospholipids and ether derivatives of neutral lipids and phospholipids.
Yamamoto N; Ngwenya BZ
Cancer Res; 1987 Apr; 47(8):2008-13. PubMed ID: 2950993
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D3 binding protein required for in vitro activation of macrophages after alkylglycerol treatment of mouse peritoneal cells.
Yamamoto N; Homma S; Haddad JG; Kowalski MA
Immunology; 1991 Nov; 74(3):420-4. PubMed ID: 1769691
[TBL] [Abstract][Full Text] [Related]
8. Activation process of macrophages after in vitro treatment of mouse lymphocytes with dodecylglycerol.
Homma S; Yamamoto N
Clin Exp Immunol; 1990 Feb; 79(2):307-13. PubMed ID: 2178824
[TBL] [Abstract][Full Text] [Related]
9. Participation of serum proteins in the inflammation-primed activation of macrophages.
Yamamoto N; Willett NP; Lindsay DD
Inflammation; 1994 Jun; 18(3):311-22. PubMed ID: 8088927
[TBL] [Abstract][Full Text] [Related]
10. Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues.
Powis G; Seewald MJ; Gratas C; Melder D; Riebow J; Modest EJ
Cancer Res; 1992 May; 52(10):2835-40. PubMed ID: 1316230
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of antibody production by lysophosphatidylcholine and alkylglycerol.
Ngwenya BZ; Foster DM
Proc Soc Exp Biol Med; 1991 Jan; 196(1):69-75. PubMed ID: 1984244
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of growth factor-dependent inositol phosphate Ca2+ signaling by antitumor ether lipid analogues.
Seewald MJ; Olsen RA; Sehgal I; Melder DC; Modest EJ; Powis G
Cancer Res; 1990 Aug; 50(15):4458-63. PubMed ID: 2369723
[TBL] [Abstract][Full Text] [Related]
13. Cyclic oxygen analogues of alkyl-lysophospholipids. Synthesis and neoplastic cell growth inhibitory properties.
Houlihan WJ; Lee ML; Munder PG; Winslow CM; Cheon SH; D'Aries FJ; DeLillo AK; Jaeggi CS; Mason RB; Parrino VA
J Lipid Mediat; 1990; 2(5):295-307. PubMed ID: 2133273
[TBL] [Abstract][Full Text] [Related]
14. Increased membrane permeability for an antitumoral alkyl lysophospholipid in sensitive tumor cells.
Storch J; Munder PG
Lipids; 1987 Nov; 22(11):813-9. PubMed ID: 3444371
[TBL] [Abstract][Full Text] [Related]
15. Superoxide production by macrophages stimulated in vivo with synthetic ether lipids.
Schreiber BM; Layne MD; Modest EJ
Lipids; 1994 Apr; 29(4):237-42. PubMed ID: 8177017
[TBL] [Abstract][Full Text] [Related]
16. Induction of apoptosis in human mitogen-activated peripheral blood T-lymphocytes by the ether phospholipid ET-18-OCH3: involvement of the Fas receptor/ligand system.
Cabaner C; Gajate C; Macho A; Muñoz E; Modolell M; Mollinedo F
Br J Pharmacol; 1999 Jun; 127(4):813-25. PubMed ID: 10433487
[TBL] [Abstract][Full Text] [Related]
17. Involvement of c-Jun NH2-terminal kinase activation and c-Jun in the induction of apoptosis by the ether phospholipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.
Gajate C; Santos-Beneit A; Modolell M; Mollinedo F
Mol Pharmacol; 1998 Apr; 53(4):602-12. PubMed ID: 9547349
[TBL] [Abstract][Full Text] [Related]
18. A defect in the inflammation-primed macrophage-activation cascade in osteopetrotic rats.
Yamamoto N; Lindsay DD; Naraparaju VR; Ireland RA; Popoff SN
J Immunol; 1994 May; 152(10):5100-7. PubMed ID: 8176226
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of orally administered rac-1-O-[1'-14C]dodecylglycerol and nutritional effects of dietary rac-1-O-dodecylglycerol in mice.
Weber N
J Lipid Res; 1985 Dec; 26(12):1412-20. PubMed ID: 4086944
[TBL] [Abstract][Full Text] [Related]
20. Synergism between penicillin G and the antimicrobial ether lipid, rac-1-dodecylglycerol, acting below its critical micelle concentration.
Ved HS; Gustow E; Pieringer RA
Lipids; 1990 Feb; 25(2):119-21. PubMed ID: 2329923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
